RasGAP-derived fragment N increases the resistance of beta cells towards apoptosis in NOD mice and delays the progression from mild to overt diabetes

Autor: Hadi Khalil, Nieves Peltzer, Christian Widmann, Jiang-Yan Yang, Evrim Jaccard, Natasa Bulat, Gilles Dubuis
Rok vydání: 2011
Předmět:
Time Factors
Mouse
medicine.medical_treatment
Apoptosis
Autoimmunity
Nod
Mice
0302 clinical medicine
Endocrinology
Mice
Inbred NOD

Insulin-Secreting Cells
Molecular Cell Biology
NOD mice
0303 health sciences
education.field_of_study
Multidisciplinary
Cell Death
Animal Models
ras GTPase-Activating Proteins
030220 oncology & carcinogenesis
Disease Progression
Medicine
Female
Beta cell
Signal Transduction
Research Article
Cell type
medicine.medical_specialty
Science
Transgene
Population
Biology
03 medical and health sciences
Model Organisms
Internal medicine
Cell Line
Tumor

medicine
Diabetes Mellitus
Animals
education
030304 developmental biology
Diabetic Endocrinology
Type 1 diabetes
Insulin
Diabetes Mellitus Type 1
Diabetes Mellitus Type 2
medicine.disease
Peptide Fragments
Rats
Diabetes Mellitus
Type 1

Gene Expression Regulation
Apoptosis/drug effects
Autoimmunity/drug effects
Diabetes Mellitus/immunology
Diabetes Mellitus/metabolism
Diabetes Mellitus
Type 1/immunology

Diabetes Mellitus
Type 1/metabolism

Insulin-Secreting Cells/drug effects
Insulin-Secreting Cells/metabolism
Peptide Fragments/metabolism
Peptide Fragments/pharmacology
Signal Transduction/drug effects
ras GTPase-Activating Proteins/chemistry
Zdroj: PLOS ONE
PLoS One, vol. 6, no. 7, pp. e22609
PLoS ONE
PLoS ONE, Vol 6, Iss 7, p e22609 (2011)
Popis: The caspase-3-generated RasGAP N-terminal fragment (fragment N) inhibits apoptosis in a Ras-PI3K-Akt-dependent manner. Fragment N protects various cell types, including insulin-secreting cells, against different types of stresses. Whether fragment N exerts a protective role during the development of type 1 diabetes is however not known. Non-obese diabetic (NOD) mice represent a well-known model for spontaneous development of type 1 diabetes that shares similarities with the diseases encountered in humans. To assess the role of fragment N in type 1 diabetes development, a transgene encoding fragment N under the control of the rat insulin promoter (RIP) was back-crossed into the NOD background creating the NOD-RIPN strain. Despite a mosaic expression of fragment N in the beta cell population of NOD-RIPN mice, islets isolated from these mice were more resistant to apoptosis than control NOD islets. Islet lymphocytic infiltration and occurrence of a mild increase in glycemia developed with the same kinetics in both strains. However, the period of time separating the mild increase in glycemia and overt diabetes was significantly longer in NOD-RIPN mice compared to the control NOD mice. There was also a significant decrease in the number of apoptotic beta cells in situ at 16 weeks of age in the NOD-RIPN mice. Fragment N exerts therefore a protective effect on beta cells within the pro-diabetogenic NOD background and this prevents a fast progression from mild to overt diabetes.
Databáze: OpenAIRE